Directeur General jobs in United Arab Emirates

The CEO will be responsible for transforming a patented hospital-based research project into a robust medtech startup capable of bringing an implantable medical device (class III) to market.

Key responsibilities include :

• Define the company vision and the regulatory, technical, and commercial roadmap.
• Structure the organization (governance, legal setup, financing, partnerships).
• Build a strong company culture focused on quality, innovation, and clinical impact.

• Develop and execute the fundraising strategy (dilutive and non-dilutive).
• Engage with deeptech / medtech investors, public funding bodies, and specialized funds.
• Manage budgets and supervise external resources.

• Oversee prototype development and the overall R&D roadmap.
• Contribute to the regulatory strategy (CE marking, FDA) with specialized consultants.
• Initiate early-stage quality documentation (ISO 13485).
• Coordinate progress on preclinical testing (in-vitro and in-vivo).

• Collaborate closely with clinicians at the University Hospital of Bordeaux.
• Build a strong network of experts : engineers, CROs, manufacturers, KOLs, consultants, and industry partners.
• Represent the project within the medtech ecosystem and to relevant institutions.

We are seeking a CEO capable of embodying the company’s vision and leading a high-impact clinical and technological project. The ideal candidate will bring strong leadership, strategic insight, and a proven track record in the medtech sector.

• Minimum of 10 years of proven, successful experience in the medtech industry , ideally involving implantable or cardiac transcatheter medical devices.
• Deep understanding of the medical device development lifecycle (ISO 13485, CE marking, FDA pathways, preclinical and clinical development).
• Demonstrated experience in startup creation, early-stage leadership, or scaling deeptech / medtech ventures.
• Strong ability to secure both dilutive and non-dilutive funding.
• Excellent leadership, communication, and team-building skills, with the capacity to align clinicians, engineers, researchers, and industrial partners around a shared vision.

• Experience in interventional cardiology, interventional radiology, or transcatheter technologies.
• Expertise in cardiac implants such as valves, stents, or delivery systems.
• Prior involvement in complex regulatory strategies (Class IIb / III devices).

The company is developing a breakthrough innovation in structural cardiology : an intra-cardiac implant delivered via a transcatheter approach, designed to address left ventricular outflow tract obstruction—a complex and insufficiently treated condition.

The startup emerged from research conducted at the University Hospital of Bordeaux, with the participation the local TTO (+500K€ invest).

The project is grounded in strong clinical expertise and a bold technological vision, aiming to transform a clinically identified need into a concrete therapeutic solution.

The company is entering a strategic development phase, progressing from prototyping to early preclinical validation, with the goal of creating a safe, reliable device that addresses a major unmet clinical need.